
Syneos Health SYNH
Quarterly report 2023-Q2
added 05-16-2026
Syneos Health EV/EBITDA Ratio 2011-2026 | SYNH
Annual EV/EBITDA Ratio Syneos Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.06 | 22.6 | 23.8 | 22.1 | 21.9 | 45.1 | 17.5 | 16.1 | 16.6 | 9.56 | 20.8 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 45.1 | 7.06 | 20.3 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
2.04 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | ||
|
Celcuity
CELC
|
-32.4 | $ 92.59 | 5.9 % | $ 4.33 B | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 4.5 | -10.89 % | $ 5.99 M | ||
|
Fulgent Genetics
FLGT
|
-8.71 | $ 18.5 | 1.04 % | $ 569 M | ||
|
Castle Biosciences
CSTL
|
-227 | $ 21.08 | 4.77 % | $ 611 M | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.496 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
20 | $ 151.82 | -0.28 % | $ 11.9 B | ||
|
Illumina
ILMN
|
22.1 | $ 160.03 | 1.26 % | $ 24.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-38.2 | $ 130.12 | 4.19 % | $ 16.3 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 22.75 | 3.64 % | $ 1.21 B | ||
|
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.74 | 3.57 % | $ 7.7 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 11.44 | 4.47 % | $ 1.47 B | ||
|
Genetron Holdings Limited
GTH
|
-0.932 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
14.3 | $ 19.75 | 2.17 % | $ 442 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 99.98 | -0.03 % | $ 6.75 B | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 189.85 | 1.83 % | $ 9.41 B | ||
|
Pacific Biosciences of California
PACB
|
-2.24 | $ 1.37 | -0.72 % | $ 411 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 466.79 | 1.94 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 162.79 | 2.1 % | $ 24 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 4.54 | 3.42 % | $ 420 M | ||
|
Natera
NTRA
|
-112 | $ 222.82 | 4.38 % | $ 30.5 B | ||
|
Personalis
PSNL
|
-4.87 | $ 9.75 | -2.89 % | $ 870 M | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 26.5 | 2.63 % | $ 25.1 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 7.43 | 4.21 % | $ 310 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.05 | -0.92 % | $ 4.71 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 271.24 | 3.52 % | $ 22.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 70.06 | 0.03 % | $ 4.19 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 494.07 | 5.23 % | $ 186 B | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.66 | -2.32 % | $ 237 M | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.29 | 2.43 % | $ 2.01 B | ||
|
Waters Corporation
WAT
|
60.2 | $ 371.15 | 2.15 % | $ 22.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 204.53 | 3.71 % | $ 22.7 B |